{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:12:09Z","timestamp":1762506729977,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.brachy.2015.12.004","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T08:47:14Z","timestamp":1454057234000},"page":"147-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"Jure","family":"Murgic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padraig","family":"Warde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Catton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-9651","authenticated-orcid":false,"given":"Anna","family":"Simeonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessamine","family":"Abed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"O'Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2015.12.004_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.critrevonc.2011.11.001","article-title":"How to select the optimal therapy for early-stage prostate cancer","volume":"83","author":"Kollmeier","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.brachy.2015.12.004_bib2","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: alpha\/beta\u00a0= 1.4 (0.9-2.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.brachy.2013.07.004","article-title":"Point: there is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients","volume":"12","author":"Spratt","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.12.004_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.radonc.2011.08.022","article-title":"Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?","volume":"100","author":"Morton","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2015.12.004_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1148\/radiol.2382041905","article-title":"Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms","volume":"238","author":"Wang","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.brachy.2015.12.004_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.rcl.2006.10.008","article-title":"Imaging of prostate cancer","volume":"45","author":"Akin","year":"2007","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.brachy.2015.12.004_bib7","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis","author":"de Rooij","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2015.12.004_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.eururo.2014.10.033","article-title":"Use of the prostate imaging reporting and data system (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis","volume":"67","author":"Hamoen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2015.12.004_bib9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.brachy.2015.12.004_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"Prostate Imaging - Reporting and Data System (PI-RADS): 2015, Version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2015.12.004_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijrobp.2009.02.019","article-title":"Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy","volume":"76","author":"McLaughlin","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2005.02.036","article-title":"Functional anatomy of the prostate: implications for treatment planning","volume":"63","author":"McLaughlin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijrobp.2009.08.040","article-title":"Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI","volume":"78","author":"Fuchsjager","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2012.01.009","article-title":"Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy","volume":"84","author":"Riaz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brachy.2012.03.002","article-title":"A phantom study to assess accuracy of needle identification in real-time planning of ultrasound-guided high-dose-rate prostate implants","volume":"12","author":"Schmid","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.12.004_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1148\/radiol.14122681","article-title":"MR-guided prostate biopsy for planning of focal salvage after radiation therapy","volume":"274","author":"Menard","year":"2015","journal-title":"Radiology"},{"issue":"Suppl","key":"10.1016\/j.brachy.2015.12.004_bib17","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.brachy.2014.02.260","article-title":"Salvage MRI-guided and tumor-targeted HDR prostate brachytherapy after external beam radiotherapy brachytherapy","volume":"13","author":"Pulvirenti","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.12.004_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mrm.20138","article-title":"System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner","volume":"52","author":"Susil","year":"2004","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.brachy.2015.12.004_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.12.004_bib20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib21","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ijrobp.2004.01.016","article-title":"MRI-guided HDR prostate brachytherapy in standard 1.5T scanner","volume":"59","author":"Menard","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1754-9485.12107","article-title":"MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer","volume":"58","author":"Chang","year":"2014","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.brachy.2015.12.004_bib23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jrr\/rrt027","article-title":"The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer","volume":"54","author":"Yoshioka","year":"2013","journal-title":"J Radiat Res"},{"key":"10.1016\/j.brachy.2015.12.004_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brachy.2013.08.004","article-title":"Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning","volume":"13","author":"Batchelar","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.12.004_bib25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0360-3016(99)00477-0","article-title":"Needle displacement during HDR brachytherapy in the treatment of prostate cancer","volume":"46","author":"Damore","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brachy.2012.03.007","article-title":"Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy","volume":"12","author":"Bowes","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.12.004_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2009.08.048","article-title":"Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321","volume":"78","author":"Hsu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prro.2013.02.011","article-title":"Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose","volume":"4","author":"Hsu","year":"2014","journal-title":"Pract Radiat Oncol"},{"year":"2015","series-title":"RTOG 0924 Protocol Information","key":"10.1016\/j.brachy.2015.12.004_bib29"},{"key":"10.1016\/j.brachy.2015.12.004_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"issue":"Suppl","key":"10.1016\/j.brachy.2015.12.004_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijrobp.2007.07.1450","article-title":"The role of needle trauma in the development of urinary toxicity following prostate high dose rate (HDR) brachytherapy","volume":"69","author":"Boyea","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.12.004_bib32","article-title":"Towards personalized statistical deformable model and hybrid Point matching for robust MR-TRUS registration","author":"Wang","year":"2015","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.brachy.2015.12.004_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1148\/radiol.14140221","article-title":"Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study","volume":"274","author":"Penzkofer","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.brachy.2015.12.004_bib34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.eururo.2014.08.077","article-title":"Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients","volume":"67","author":"Baco","year":"2015","journal-title":"Eur Urol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847211500611X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847211500611X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:09:56Z","timestamp":1761530996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153847211500611X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S153847211500611X"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2015.12.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2015.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}